Anna KlugScientist I at Just-Evotec Biologics
Anna Klug is a process development scientist in the cell line development group at Just Evotec Biologics. During her 3 years at Just, she has led the development of multiple cell lines expressing therapeutic drug candidates and contributed to the development of several internal CHO host cell lines. Additionally, Anna was an integral member in the development of the first induced pluripotent stem cell (iPSC) platform at Just for beta cell replacement therapy. Prior to joining Just, Anna received her bachelor’s degree in bioengineering from the University of Washington and researched cardiac regeneration with iPSCs.